Przejdź do zawartości
· Wypełniacze skórne
SKU 11135

Saypha Lips Lidocaine

Dostępny
Objętość
1 x 1 mL
Laboratorium
Croma-Pharma GmbH
Pochodzenie
Austria
Wskazanie
Lip augmentation and contour definition
Obszary zabiegowe
Cena hurtowa i historia tylko dla zweryfikowanych
allpara zaopatruje licencjonowanych specjalistów. Zaloguj się lub załóż konto B2B, aby zobaczyć aktualne ceny, progi ilościowe i historię cen.

Saypha Lips Lidocaine is a viscoelastic implant from Croma-Pharma in Austria, designed for lip augmentation and moderate to severe nasolabial folds. Practitioners must inject it into the mid to deep dermis or submucosa, using the needle or an affixed 25G x 2 inch or 22G x 2 3/4 inch cannula. Its cross-linked hyaluronic acid from Streptococcus equi bacteria, phosphate buffered at pH 6.7 to 7.3, gives 2.3% sodium hyaluronate (23 mg/mL) and lidocaine HCl 0.3%. Each box holds one pre-filled 1.0 mL syringe with two 27G 1/2 inch needles, three patient record labels and an international implant card.

Najważniejsze zalety: Saypha Lips Lidocaine

  • Indicated for lip augmentation and for correcting moderate to severe nasolabial folds
  • Cross-linked sodium hyaluronate at 23 mg/mL, of non-animal origin from Streptococcus equi bacteria
  • Contains lidocaine hydrochloride 0.3%, which reduces pain and discomfort during injection
  • Can be delivered by needle or by cannula, a 25G x 2 inch or 22G x 2 3/4 inch
  • Cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres
  • BDDE cross-linking agent present at 2 ppm or less
  • Supplied with two 27G 1/2 inch needles, three patient record labels and an international implant card
  • Manufactured by Croma-Pharma in Austria
Najważniejsze informacje
Marka SAYPHA
Producent Croma-Pharma GmbH
Kraj pochodzenia Austria
Certyfikacja CE marked 0123. The needles supplied are CE marked 0197
Skład Cross-linked sodium hyaluronate 2.3%, equivalent to 23 mg/mL, obtained from Streptococcus equi bacteria, with lidocaine hydrochloride 0.3%, sodium chloride 0.75%, disodium phosphate dodecahydrate 0.24%, sodium dihydrogen phosphate dihydrate 0.05% and BDDE cross-linking agent at 2 ppm or less, in water for injection, phosphate buffered at pH 6.7 to 7.3. Mean cross-linking degree 0.5 to 1.0%, typical particle size approximately 316 micrometres
Opakowanie 1 pre-filled syringe x 1.0 mL with two 27G 1/2 inch needles, three patient record labels, an international implant card and a link to the patient information leaflet. A 25G x 2 inch or 22G x 2 3/4 inch cannula may be affixed instead of the needle
Rodzaj zastosowania For professional use. Injectable lip filler with anaesthetic
Objętość / Rozmiar 1 x 1 mL
Głębokość iniekcji Mid to deep dermis or submucosa
Protokół / Czas trwania For healthy adults, the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session

Wskazania i zastosowanie profesjonalne

Główne wskazania

  • Lip augmentation, to make the lips fuller
  • Moderate to severe nasolabial folds, the deep lines running from the edge of the nose to the outer corners of the mouth
  • For adults aged 18 or older; not to be used in people under the age of 18

Zastosowanie profesjonalne

Saypha Lips Lidocaine is intended for an appropriately trained healthcare professional who is qualified or accredited in accordance with national law, and is not intended to be used by lay persons. It is injected into the mid to deep dermis or submucosa, using the supplied 27G 1/2 inch needle or, where the practitioner prefers, a 25G x 2 inch or 22G x 2 3/4 inch cannula. For healthy adults the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session; where other forms of lidocaine are used concurrently, whether topical or injected, the maximum total dose must be considered. Patients should avoid strenuous exercise and exposure to extensive sun or heat in the first 48 hours after injection.

Obszary zabiegowe

  • Lips, by submucosal injection
  • Nasolabial folds, by mid to deep dermis injection

Profil pacjenta

For adults 18 years of age or older, assessed as suitable by the treating practitioner. It must not be used in those who tend to develop hypertrophic scars, have pigment disorders or a susceptibility to keloid formation, since treatment may trigger these complications. It must not be used in those known to be hypersensitive to hyaluronic acid, gram-positive bacterial proteins, lidocaine hydrochloride or amide-type local anaesthetics, since treatment may trigger allergic reactions of varying severity. It must not be used in pregnant or breast-feeding women, or in individuals younger than 18 years of age.

Jak działa Saypha Lips Lidocaine ​

Saypha Lips Lidocaine works through cross-linked hyaluronic acid at 23 mg/mL, placed in the lip submucosa or the mid to deep dermis where it adds volume. The gel is cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres, and the BDDE cross-linking agent is present at 2 ppm or less. The lidocaine hydrochloride at 0.3% is integrated into the implant in an ancillary role, to reduce pain and discomfort caused by the injection, which matters in the lip more than almost anywhere else. It does not change how the gel behaves in tissue.

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty SAYPHA od zweryfikowanych dostawców, z pełną identyfikowalnością partii i wsparciem ekspertów. Obsługujemy kliniki i specjalistów medycyny estetycznej, oferując produkty z certyfikatem CE, szybką dostawę na terenie całej UE z naszego magazynu w UE oraz konkurencyjne ceny hurtowe. Najważniejsze są dla nas bezpieczeństwo, satysfakcja i efekty Twoich pacjentów - z dedykowanym wsparciem posprzedażowym dla Twojego spokoju.

Najczęściej zadawane pytania

How does Saypha Lips Lidocaine differ from Saypha Filler Lidocaine?

Both carry 2.3% sodium hyaluronate with lidocaine 0.3% and share the same registered indication and placement, the mid to deep dermis or submucosa. Saypha Lips Lidocaine additionally documents a cannula option, a 25G x 2 inch or 22G x 2 3/4 inch cannula in place of the supplied needle.

Can Saypha Lips Lidocaine be injected with a cannula?

Yes. Two 27G 1/2 inch needles are supplied, and a 25G x 2 inch or 22G x 2 3/4 inch cannula may be affixed instead, following the same assembly steps.

Więcej od Croma-Pharma

Zobacz laboratorium

Alternatywy dla kliniki

Wszystkie produkty

Saypha Lips Lidocaine

Dostępny
Oznaczenie CE Oznaczenie CE Saypha Lips Lidocaine
Ceny tylko dla zweryfikowanych
Zaloguj się lub załóż konto B2B, aby zobaczyć swoją cenę.
Konto B2B

Saypha Lips Lidocaine is a viscoelastic implant from Croma-Pharma in Austria, designed for lip augmentation and moderate to severe nasolabial folds. Practitioners must inject it into the mid to deep dermis or submucosa, using the needle or an affixed 25G x 2 inch or 22G x 2 3/4 inch cannula. Its cross-linked hyaluronic acid from Streptococcus equi bacteria, phosphate buffered at pH 6.7 to 7.3, gives 2.3% sodium hyaluronate (23 mg/mL) and lidocaine HCl 0.3%. Each box holds one pre-filled 1.0 mL syringe with two 27G 1/2 inch needles, three patient record labels and an international implant card.

Najważniejsze zalety: Saypha Lips Lidocaine

  • Indicated for lip augmentation and for correcting moderate to severe nasolabial folds
  • Cross-linked sodium hyaluronate at 23 mg/mL, of non-animal origin from Streptococcus equi bacteria
  • Contains lidocaine hydrochloride 0.3%, which reduces pain and discomfort during injection
  • Can be delivered by needle or by cannula, a 25G x 2 inch or 22G x 2 3/4 inch
  • Cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres
  • BDDE cross-linking agent present at 2 ppm or less
  • Supplied with two 27G 1/2 inch needles, three patient record labels and an international implant card
  • Manufactured by Croma-Pharma in Austria
Najważniejsze informacje
Marka SAYPHA
Producent Croma-Pharma GmbH
Kraj pochodzenia Austria
Certyfikacja CE marked 0123. The needles supplied are CE marked 0197
Skład Cross-linked sodium hyaluronate 2.3%, equivalent to 23 mg/mL, obtained from Streptococcus equi bacteria, with lidocaine hydrochloride 0.3%, sodium chloride 0.75%, disodium phosphate dodecahydrate 0.24%, sodium dihydrogen phosphate dihydrate 0.05% and BDDE cross-linking agent at 2 ppm or less, in water for injection, phosphate buffered at pH 6.7 to 7.3. Mean cross-linking degree 0.5 to 1.0%, typical particle size approximately 316 micrometres
Opakowanie 1 pre-filled syringe x 1.0 mL with two 27G 1/2 inch needles, three patient record labels, an international implant card and a link to the patient information leaflet. A 25G x 2 inch or 22G x 2 3/4 inch cannula may be affixed instead of the needle
Rodzaj zastosowania For professional use. Injectable lip filler with anaesthetic
Objętość / Rozmiar 1 x 1 mL
Głębokość iniekcji Mid to deep dermis or submucosa
Protokół / Czas trwania For healthy adults, the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session

Wskazania i zastosowanie profesjonalne

Główne wskazania

  • Lip augmentation, to make the lips fuller
  • Moderate to severe nasolabial folds, the deep lines running from the edge of the nose to the outer corners of the mouth
  • For adults aged 18 or older; not to be used in people under the age of 18

Zastosowanie profesjonalne

Saypha Lips Lidocaine is intended for an appropriately trained healthcare professional who is qualified or accredited in accordance with national law, and is not intended to be used by lay persons. It is injected into the mid to deep dermis or submucosa, using the supplied 27G 1/2 inch needle or, where the practitioner prefers, a 25G x 2 inch or 22G x 2 3/4 inch cannula. For healthy adults the maximum total dose of lidocaine hydrochloride should not exceed 300 mg, or 4.5 mg per kg body weight, whichever is less, per session; where other forms of lidocaine are used concurrently, whether topical or injected, the maximum total dose must be considered. Patients should avoid strenuous exercise and exposure to extensive sun or heat in the first 48 hours after injection.

Obszary zabiegowe

  • Lips, by submucosal injection
  • Nasolabial folds, by mid to deep dermis injection

Profil pacjenta

For adults 18 years of age or older, assessed as suitable by the treating practitioner. It must not be used in those who tend to develop hypertrophic scars, have pigment disorders or a susceptibility to keloid formation, since treatment may trigger these complications. It must not be used in those known to be hypersensitive to hyaluronic acid, gram-positive bacterial proteins, lidocaine hydrochloride or amide-type local anaesthetics, since treatment may trigger allergic reactions of varying severity. It must not be used in pregnant or breast-feeding women, or in individuals younger than 18 years of age.

Jak działa Saypha Lips Lidocaine ​

Saypha Lips Lidocaine works through cross-linked hyaluronic acid at 23 mg/mL, placed in the lip submucosa or the mid to deep dermis where it adds volume. The gel is cross-linked to a mean degree of 0.5 to 1.0% with a typical particle size of approximately 316 micrometres, and the BDDE cross-linking agent is present at 2 ppm or less. The lidocaine hydrochloride at 0.3% is integrated into the implant in an ancillary role, to reduce pain and discomfort caused by the injection, which matters in the lip more than almost anywhere else. It does not change how the gel behaves in tissue.

Dlaczego warto zamawiać w Allpara

Allpara oferuje oryginalne, sprawdzone produkty SAYPHA z pełną identyfikowalnością partii, produktami z certyfikatem CE, szybką dostawą na terenie całej UE i fachowym wsparciem posprzedażowym.

Najczęściej zadawane pytania

How does Saypha Lips Lidocaine differ from Saypha Filler Lidocaine?

Both carry 2.3% sodium hyaluronate with lidocaine 0.3% and share the same registered indication and placement, the mid to deep dermis or submucosa. Saypha Lips Lidocaine additionally documents a cannula option, a 25G x 2 inch or 22G x 2 3/4 inch cannula in place of the supplied needle.

Can Saypha Lips Lidocaine be injected with a cannula?

Yes. Two 27G 1/2 inch needles are supplied, and a 25G x 2 inch or 22G x 2 3/4 inch cannula may be affixed instead, following the same assembly steps.

Więcej od Croma-Pharma

Zobacz laboratorium →
* Produkt do użytku profesjonalnego. Opakowanie może się różnić w zależności od partii lub rynku. Pełne zalecenia i przeciwwskazania znajdziesz w dołączonej instrukcji użycia (IFU).